Indian Army Tender

The Indian Army has issued a formal invitation for competitive bids for CATEGORY: ADALIMUMAB 40MG PER0 POINT8ML INJ , BIPHASIC ISOPHANE INSULIN 30PERCNT INSULIN ISOPHAN MIXTARD , INJ DENOSUMAB SOLUTION 60 MG PERML PROLLIA , HYOSCINE BUTYLBROMIDE INJECTION 20MG PERML , INJ PHENIRAMINE 22 POINT75 MG PERML , INJ ATROPINE 0 POINT6 MG COMMA1 ML , INJ CALCIUM GLUCONATE 10 PERCNT , INJ CEFOTAXIME SODIUM 1 GM , INJ DEXTORSE 5PERCNT , INJ DEXTROSE 25 PERCNT , INJ METHYLCOBA VIT B6 PYRIDOXNE NICOTINAMIDE NEUROBION , INJ NORMAL SALINE 100 ML , INJ RABIPUR VACCINE 1 ML , INJ TT TETANUS TOXOID 5 ML , INJ DICLOFENAC 25MG PERML 3ML VOVERAN , INJ DICYCLOMINE 20 MG , INJ ETOPHYLLNE 84 POINT7 PLUS THEOPHYLLINE 25 POINT3 PERML , INJ GLARGINE 100IU PERML 3ML PEN , INJ HUMAN INSULIN GLARGINE 300IU PERML 3ML , INJ INSULIN ISOPHANE PERNPH HUMAN INSULIN , INJ IRON SUCROSE , INJ LIGNOCAINE 2PERCNT WITH ADRENALINE , INJ METHYLCOBALAMIN 1500 MCG , INJ VITAMIN D3 600000IU ARACHITOL , INSULIN ASPART INSULIN ASPART PROTAMINE , INSULIN HIGHLY PURIFIED ISOPHANE HUMAN NPH 40IU PERML , INSULIN HUMALOG LISPRO INJ RECOMBINAN DNA ORIGIN , CILNIDIPINE 10 MG TAB , CILNIDIPINE 20 MG TAB , CILOSTAZOL 100 MG TAB , CILOSTAZOL 50MG TAB , CINNARIZINE 25MG TAB STUGERON , CLOBAZAM 5 MG TAB , CLONIDINE 100 MCG TAB ARKAMINE , CLOPIDOGREL 75 MG PLUS ASPIRIN 75 MG TAB , CLOTRIMAZOLE 100MG VAGINAL TABLETS , CLOZAPINE 50 MG TAB , ALOVERA AND VITAMIN E LOTION , BACLOFEN 10 MG TAB , BECLOMETHASONE DIPROPIONATE PER DOSE , NEBIVOLOL 5 MG TAB , NEUROBION FORTE TAB , NEVIRAPINE 200 MG TAB , NICORANDIL 5 MG TAB , NITRAZEPAM 5 MG , NITROGLYCERIN 2 POINT6MG TAB , PREGABALIN SR 75 MG TAB , SEMAGLUTIDE 3 MG TAB , TORSEMIDE 10 MG TAB in Ahmednagar, Maharashtra, with an estimated contract value of Rs. 56,66,882. The bid opening date for this tender is 09-06-2025 and the last date for bid submission is 30-06-2025. Interested bidders for Indian Army tender can download the important documents here to check the scope of work, eligibility criteria and technical requirements.